A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

PHASE3RecruitingINTERVENTIONAL

Enrollment

216

Participants

Timeline

Start Date

August 11, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

November 30, 2026

Conditions

Obstructive Hypertrophic Cardiomyopathy

Interventions

DRUG

HRS-1893 Tablets

HRS-1893 tablets.

DRUG

HRS-1893 Placebo Tablets

HRS-1893 placebo tablets.

Trial Locations (1)

RECRUITING

Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY